{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:59:12Z","timestamp":1790085552688,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008963","name":"Spanish Society of Medical Oncology","doi-asserted-by":"publisher","award":["2024-3"],"award-info":[{"award-number":["2024-3"]}],"id":[{"id":"10.13039\/501100008963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010769","name":"Axencia Galega de Innovacion","doi-asserted-by":"publisher","award":["12_IN606D_2023_2548529"],"award-info":[{"award-number":["12_IN606D_2023_2548529"]}],"id":[{"id":"10.13039\/501100010769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Gobierno de Espana Ministerio de Ciencia e Innovacion","doi-asserted-by":"publisher","award":["PID2023-150296OB-I00"],"award-info":[{"award-number":["PID2023-150296OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biopha.2026.119816","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T11:04:52Z","timestamp":1786532692000},"page":"119816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Proof-of-concept study in patient-derived organoids from malignant pleural effusion for functional testing in thoracic tumors"],"prefix":"10.1016","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0834-8242","authenticated-orcid":false,"given":"Rocio","family":"Ferreiro-Miguens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Diez-Grandio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8603-1259","authenticated-orcid":false,"given":"Roi","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9023-0429","authenticated-orcid":false,"given":"Luc\u00eda","family":"Ferreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7672-9867","authenticated-orcid":false,"given":"Jorge","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0640-5776","authenticated-orcid":false,"given":"Mar\u00eda","family":"Otero-Alen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihab","family":"Abdulkader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6579-4903","authenticated-orcid":false,"given":"Beatriz","family":"Bernardez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3359-5867","authenticated-orcid":false,"given":"Eduardo","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3533-7781","authenticated-orcid":false,"given":"Miguel","family":"Abal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0742-1209","authenticated-orcid":false,"given":"Luis","family":"Leon-Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10299","key":"10.1016\/j.biopha.2026.119816_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.biopha.2026.119816_bib2","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3390\/ijms26052049","article-title":"Lung Cancer\u2014Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature)","volume":"26","author":"Smolarz","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119816_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non\u2013small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"New. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.biopha.2026.119816_bib4","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel\u2013carboplatin alone or with bevacizumab for non\u2013small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"New. Engl. J. Med."},{"issue":"10454","key":"10.1016\/j.biopha.2026.119816_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(24)01029-8","article-title":"New promises and challenges in the treatment of advanced non-small-cell lung cancer","volume":"404","author":"Meyer","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119816_bib6","doi-asserted-by":"crossref","first-page":"iv192","DOI":"10.1093\/annonc\/mdy275","article-title":"Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Planchard","year":"2018","journal-title":"Ann. Oncol."},{"issue":"19","key":"10.1016\/j.biopha.2026.119816_bib7","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.3390\/jcm13195837","article-title":"Malignant Pleural Mesothelioma: A Comprehensive Review","volume":"13","author":"Jain","year":"2024","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.biopha.2026.119816_bib8","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.21037\/jtd-20-2761","article-title":"Epidemiology, diagnosis and treatment of the malignant pleural mesothelioma, a narrative review of literature","volume":"13","author":"Schumann","year":"2021","journal-title":"J. Thorac. Dis."},{"issue":"10","key":"10.1016\/j.biopha.2026.119816_bib9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or Carboplatin\u2013Paclitaxel in Pulmonary Adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"New. Engl. J. Med."},{"issue":"10066","key":"10.1016\/j.biopha.2026.119816_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: current therapies and new targeted treatments","volume":"389","author":"Hirsch","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.biopha.2026.119816_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.annonc.2021.11.005","article-title":"Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2606","volume":"33","author":"Popat","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2026.119816_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.961440","article-title":"Current status of and progress in the treatment of malignant pleural effusion of lung cancer","volume":"12","author":"Zhao","year":"2023","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119816_bib13","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.chest.2021.06.074","article-title":"Malignant Pleural Effusion in Malignant Pleural Mesothelioma","volume":"160","author":"Muruganandan","year":"2021","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.biopha.2026.119816_bib14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.medcli.2022.03.007","article-title":"Mesotelioma pleural","volume":"159","author":"Porcel","year":"2022","journal-title":"Med. Clin. (Barc. )"},{"key":"10.1016\/j.biopha.2026.119816_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107542","article-title":"Establishing mesothelioma patient-derived organoid models from malignant pleural effusions","volume":"191","author":"Hocking","year":"2024","journal-title":"Lung Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2026.119816_bib16","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/thoraxjnl-2020-216602","article-title":"Use of preclinical models for malignant pleural mesothelioma","volume":"76","author":"Shamseddin","year":"2021","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.biopha.2026.119816_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40164-026-00743-x","article-title":"Organoids for disease modeling and treatment: state-of-the-art","volume":"15","author":"Xu","year":"2026","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119816_bib18","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12964-023-01332-9","article-title":"Applications of lung cancer organoids in precision medicine: from bench to bedside","volume":"21","author":"Li","year":"2023","journal-title":"Cell. Commun. Signal."},{"issue":"2","key":"10.1016\/j.biopha.2026.119816_bib19","article-title":"Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study","volume":"4","author":"Wang","year":"2023","journal-title":"Cell. Rep. Med."},{"issue":"17","key":"10.1016\/j.biopha.2026.119816_bib20","doi-asserted-by":"crossref","first-page":"13208","DOI":"10.3390\/ijms241713208","article-title":"Ascites-Derived Organoids to Depict Platinum Resistance in Gynaecological Serous Carcinomas","volume":"24","author":"Arias-Diaz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119816_bib21","article-title":"Patient-derived xenograft models: Current status, challenges, and innovations in cancer research","volume":"12","author":"Liu","year":"2025","journal-title":"Genes. Dis."},{"issue":"10","key":"10.1016\/j.biopha.2026.119816_bib22","article-title":"Modeling lung adenocarcinoma metastases using patient-derived organoids","volume":"5","author":"Liu","year":"2024","journal-title":"Cell. Rep. Med."},{"issue":"14","key":"10.1016\/j.biopha.2026.119816_bib23","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1158\/1078-0432.CCR-16-3083","article-title":"Clinically Relevant Concentrations of Anticancer Drugs: A Guide for Nonclinical Studies","volume":"23","author":"Liston","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2026.119816_bib24","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1470-2045(22)00277-7","article-title":"EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study","volume":"23","author":"Zauderer","year":"2022","journal-title":"Lancet Oncol."},{"issue":"D1","key":"10.1016\/j.biopha.2026.119816_bib25","doi-asserted-by":"crossref","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","article-title":"PubChem 2025 update","volume":"53","author":"Kim","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119816_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12943-023-01901-z","article-title":"Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma","volume":"23","author":"Fang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.biopha.2026.119816_bib27","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.3390\/ijms25105355","article-title":"Mesothelioma-associated fibroblasts modulate the response of mesothelioma patient-derived organoids to chemotherapy via Interleukin-6","volume":"25","author":"Cioce","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119816_bib28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1186\/s12885-023-10966-4","article-title":"Matrigel-based organoid culture of malignant mesothelioma reproduces cisplatin sensitivity through CTR1","volume":"23","author":"Ito","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119816_bib29","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1038\/s41598-018-21200-8","article-title":"vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening","volume":"8","author":"Mazzocchi","year":"2018","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2026.119816_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189356","article-title":"Epigenetic mechanisms in non-small cell lung cancer therapy and chemoresistance","volume":"1880","author":"Xu","year":"2025","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2026.119816_bib31","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.jtho.2025.09.007","article-title":"Mesothelioma in BAP1 cancer syndrome and contribution of epigenetic","volume":"20","author":"Galateau-Sall\u00e9","year":"2025","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.biopha.2026.119816_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.semcancer.2021.01.005","article-title":"Targeting DNA methyltransferases in non-small-cell lung cancer","volume":"83","author":"Al-Yozbaki","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119816_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41392-023-01341-7","article-title":"Targeting epigenetic regulators to overcome drug resistance in cancers","volume":"8","author":"Wang","year":"2023","journal-title":"Signal. Transduct. Target. Ther."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:59:19Z","timestamp":1790081959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226008528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":33,"alternative-id":["S0753332226008528"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119816","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proof-of-concept study in patient-derived organoids from malignant pleural effusion for functional testing in thoracic tumors","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119816"}}